Corporate News Report
Stock Performance (24‑Hour Period Ending 07:17 AM CET, Monday 26 July 2026)
- Calidi Biotherapeutics (CLDI)
- Price: USD 0.64
- Change: –0.77 %
- Volume: USD 24.3 k
- Shares outstanding: 3.7 million
- Market capitalisation: USD 2.4 million
- 24‑hour trading value: USD 24.3 k
- 1‑month change: –46.25 %
- 200‑day simple moving average: USD 4.87
- 52‑week high: USD 27.04 (11 June 2025)
- 52‑week low: USD 0.62 (22 October 2026)
Peer Performance (24‑Hour Period)
| Company | Ticker | Change | Current Price | Market Capitalisation |
|---|---|---|---|---|
| Vivos Therapeutics | VVOS | +0.75 % | USD 0.13 | USD 2.7 million |
| Megan | MGN | –0.99 % | USD 2.00 | USD 2.5 million |
| Mustang Bio | MBIO | +0.27 % | USD 0.37 | USD 2.8 million |
| Invo Fertility | IVF | +6.94 % | USD 0.57 | USD 2.7 million |
Company Overview
Calidi Biotherapeutics Inc. is a clinical‑stage immuno‑oncology firm headquartered in San Diego, United States. The company focuses on developing a new generation of targeted immunotherapies that primarily attack solid tumors and train the immune system to identify and eliminate cancer cells throughout the body. Calidi Biotherapeutics markets its products globally.
